About this trial
Role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study will build on previous research by designing, in collaboration with patients, family members and professionals, an online resource to provide important information that can lower anxiety and concerns, and improve quality of life. The CHOICE-ICD resource will be easy to use, incorporating games and quizzes to encourage engagement, up to date information appropriate to each patient's needs, as well as animation clips, virtual reality, and short patient videos. CHOICE-ICD will be made available to 64 patients, in addition to normal care, awaiting or with a recently implanted ICD in Belfast and Glasgow. Patients will use the resource for 3 months. Patients and family members will then be asked to complete questionnaires and participate in semi-structured interviews. This study will develop 1st UK online resource providing information to enable patients to have greater choice and control in their care.
Eligibility criteria
Qualifiers
Patients with heart failure awaiting or with an ICD (no time restriction on implantation)
No cognitive impairment
Have contact with the patient at least 5 times per week.
Be physically and mentally capable of participation (self-assessment)
Disqualifiers
Patients, judged by their Cardiologist as physically or mentally unsuitable to complete the study.
Patients or caregivers lacking capacity to give consent.
Patients who have known pregnancy
Caregivers who's patient is unwilling to take participate
Trial design
Treatments tested in this trial
- Choice-ICD
Treatment groups
Sponsors and collaborators
University of Ulster
Lead sponsor
Belfast Health and Social Care Trust
Collaborator
Golden Jubilee National Hospital
Collaborator